AGLAF yields 944.29% · JNJ yields 2.13%● Live data
📍 AGLAF pulled ahead of the other in Year 1
Combined, AGLAF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AGLAF + JNJ for your $10,000?
T2 Metals Corp., a junior mineral exploration company, engages in the acquisition and exploration of mineral properties in Canada and the United States. The company primarily holds a 90% interest in the Sherridon copper-zinc-silver-gold property that includes 28 mining claims and 1 mineral lease covering an area of 4,968 hectares located in the Sherridon mining district, Manitoba. It also holds 100% interests in the Cora copper project, which consists of 46 granted lode mining claims covering an area of 3.84 square kilometers situated in Pinal County, Arizona; and Lida copper project that includes 33 granted lode mining claims covering an area of 2.75 square kilometers located in Esmeralda County, Nevada. The company was formerly known as Aguila Copper Corp. and changed its name to T2 Metals Corp. in October 2022. T2 Metals Corp. was incorporated in 1997 and is based in Vancouver, Canada.
Full AGLAF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.